Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the weight loss drugs.

Weight-loss drugs will be offered to millions of people on the NHS, to help them manage their health. One jab, Wegovy, is already available to some people and a second, Mounjaro, will soon be ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Though Ozempic can cause weight loss when used to treat type 2 diabetes ... want to go beyond Mounjaro and Ozempic. You can choose from tirzepatide tablets, semaglutide injections, tablets ...

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

A major new study has highlighted significant health risks associated with popular weight loss injections ... 2 diabetes, the study uncovered concerning side effects. Experimental weight-loss jab is 5 ...

Who is eligible for weight-loss jabs? UK pharmacies tighten rules amid misuse concerns - The clampdown comes after several ...

A breakthrough in weight loss medication is on the horizon. While popular drugs like Ozempic and Wegovy are only available as injections ... patients with Type 2 diabetes. However, they are ...

Many insurance companies do not cover weight loss injections unless they are for underlying conditions such as diabetes. Wegovy (semaglutide) is an injection medication that can help manage blood ...

Mounjaro and Ozempic are both diabetes drugs prescribed off-label for weight loss. That means they ... once-a-week subcutaneous (under the skin) injections. You can administer the injection ...